Uribe M, Alba A, González G, Hunter B, Heine C, Iñiguez R, Cavallieri S, Flores L, Soto P, Auad H, Zuleta R, Acuña C
Hospital Luis Calvo Mackenna, Universidad de Chile, Santiago, Chile.
Transplant Proc. 2013;45(10):3726-7. doi: 10.1016/j.transproceed.2013.08.078.
Pediatric liver transplantation is limited by donation. In the last 5 years, urgent conditions have forced transplant teams to accept donors with minor suboptimal conditions, termed "extended donor criteria." Among those, the risk of using severe hypernatremic donors (SHD) for liver transplant is not yet well established. The aim of this study is to report the outcome of pediatric patients receiving grafts from SHD.
Clinical records of patients transplanted in the last 3 years at Hospital Luis Calvo Mackenna, Santiago, Chile, were reviewed. Outcome was evaluated in terms of patient and graft survival and complications potentially associated to the donor condition.
Five of 33 deceased donor transplants presented with SHD. All recipients were waiting transplant in an acute condition, one of them in acute liver failure (ALF). No living related donor was available. Donors' serum sodium was 169 to 193 mEq/L before medical management and between 157 and 172 mEq/L at procurement. One patient died from sepsis related to biliary complications, and the patient suffering ALF developed primary graft nonfunction, received a second transplant 2 weeks later, and recovered to stable medical condition. No other complication was registered in these patients.
Our findings allow us to postulate that hypernatremic deceased donors may be used for pediatric liver transplant under special circumstances.
小儿肝移植受供体数量限制。在过去5年中,紧急情况迫使移植团队接受条件稍差的供体,即“扩大供体标准”。其中,肝移植使用严重高钠血症供体(SHD)的风险尚未明确。本研究旨在报告接受SHD供肝的小儿患者的结局。
回顾了智利圣地亚哥路易斯·卡尔沃·麦肯纳医院过去3年接受移植患者的临床记录。根据患者和移植物存活情况以及可能与供体状况相关的并发症来评估结局。
33例尸体供肝移植中有5例为SHD。所有受者均处于急性状态等待移植,其中1例为急性肝衰竭(ALF)。无活体亲属供体可用。供体在医疗处理前血清钠为169至193 mEq/L,获取时为157至172 mEq/L。1例患者死于与胆道并发症相关的败血症,患有ALF的患者发生原发性移植物无功能,2周后接受了第二次移植,并恢复到病情稳定状态。这些患者未记录到其他并发症。
我们的研究结果使我们推测,在特殊情况下,高钠血症尸体供体可用于小儿肝移植。